Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00260559 · ClinicalTrials.gov registry record
Outcomes After Esophagectomy With a Focus on Minimally Invasive Esophagectomy and Quality of Life
A clinical trial of Esophageal Cancer and Esophagectomy, sponsored by University of Pittsburgh.
- Recruiting
- Registry status
- 3,500
- Enrollment target
- 2
- Study locations
NCT00260559 is a study of Esophageal Cancer and Esophagectomy that is actively recruiting participants, run by University of Pittsburgh. The registered enrollment target is 3,500 participants, above the 471-participant average among 123 other Esophageal Cancer trials with a reported enrollment target (643% higher). The trial reports 2 study locations across 1 state.
The verdict
NCT00260559, a study of Esophageal Cancer and Esophagectomy, is actively recruiting participants, sponsored by University of Pittsburgh.
- RECRUITING
- Registry status
- 3,500 participants
- Enrollment target
- 2
- Study locations
Study Summary
To assess short and long term outcomes after minimally invasive esophagectomy compared to open esophagectomy. To compare both standard outcome measures as well as patient derived outcome measures, in particular, quality of life (QOL). To look at the applicability of this QOL instrument to this patient group.
Conditions Studied
Interventions
- PROCEDURE Questionnaires
Study Locations (2)
Pennsylvania
- University of Pittsburgh Medical Center - Department of Cardiothoracic Surgery - Pittsburgh
- UPMC - Hillman Cancer Center - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,500 participants |
| Start Date | 1999-05 |
| Est. Completion | 2050-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00260559
The ClinicalTrials.gov registry entry for NCT00260559 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 3,500 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 471-participant average among 123 other Esophageal Cancer trials with a reported enrollment target (643% higher). The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Esophageal Cancer appearing as the primary indexed condition, and to 1 intervention - of which Questionnaires is the first listed.
NCT00260559 reports 2 study locations spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00260559 about?
NCT00260559 is a clinical study titled "Outcomes After Esophagectomy With a Focus on Minimally Invasive Esophagectomy and Quality of Life". To assess short and long term outcomes after minimally invasive esophagectomy compared to open esophagectomy. To compare both standard outcome measures as well as patient derived outcome measures, in particular, quality of life (QOL). To look at the applicability of this QOL instrument to this patie...
What is the current status of trial NCT00260559?
This trial is currently recruiting. The enrollment target is 3,500 participants. The study started on 1999-05. Estimated completion is 2050-12.
What conditions does trial NCT00260559 study?
This clinical trial studies the following conditions: Esophageal Cancer, Esophagectomy.
What interventions are being tested in trial NCT00260559?
The interventions under investigation include: Questionnaires (PROCEDURE).
Who is sponsoring clinical trial NCT00260559?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00260559 being conducted?
This trial has 2 study locations across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Esophageal Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Phase 1 Trial of ZM008 as Single Agent and in Combination With Pembrolizumab in Patients With Advanced Solid Tumors
RECRUITING · Phase 1
-
Registry for Esophageal and Gastroesophageal Junction Cancer
RECRUITING
-
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
RECRUITING · Phase 1
-
Retrospective Review of Esophageal Cancer at MSKCC
RECRUITING
-
Substudy 06D: Combination Therapies in Second Line (2L) Gastroesophageal Adenocarcinoma (MK-3475-06D/Keymaker-U06)
RECRUITING · Phase 1
-
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
RECRUITING · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.